Mar 7, 2014 by Dave WilliamsonInterMune Wins Amid More Takeover RumorsInterMune pops today on buyout rumors, but is there anything substantiating the buyout talk?
Mar 6, 2014 by Dave WilliamsonWhy Zogenix, Inc. Was a House of Pain for InvestorsDid the FDA just give the green light to a dangerous drug from Zogenix?
Mar 6, 2014 by Dave WilliamsonWhy Sangamo Biosciences, Inc. Trounced the MarketSangamo Biosciences shot up 20% today, but this may still be one to watch at a distance.
Mar 5, 2014 by Dave Williamson3 Stocks Making Massive 1-Day MovesThese three winners and losers in the biotech space today moved big. Really big.
Mar 4, 2014 by Dave WilliamsonDendreon Corp.: The Biggest Loser in Biotech TodayHere's why shares of Dendreon backslid today, and lost so much of yesterday's market gain.
Mar 4, 2014 by Dave WilliamsonInsys Therapeutics: Today's Big Biotech WinnerInsys Therapeutics is today's winner in the biotech space, after shooting up 20%. Can it go higher?
Mar 2, 2014 by Dave Williamson3 Award-Winning Investing Lessons From the OscarsThe Academy Awards is more than just great films and amazing formal wear.
Feb 28, 2014 by Dave WilliamsonActivist Investors Agitating Biotechs Bring Multi-Bagger ReturnsThe success of Carl Icahn has brought increasing focus on activist investors.
Feb 27, 2014 by Dave WilliamsonQuestcor Pharmaceuticals: Another Strong Quarter Beset by Potentially Explosive AllegationsQuestcor is a strong company with growing sales, but the allegations of questionable business practices are mounting.
Feb 27, 2014 by Dave WilliamsonInstant Double Aftermath: Is InterMune Inc. In Play?After InterMune's instant double this week and killer phase 3 results, the company may be a takeover target. So, who do we think is buying?
Feb 27, 2014 by Dave WilliamsonAnother Day, Another Big Pharma BreakupMerck may be on the verge of making a very big move.
Feb 27, 2014 by Dave WilliamsonWhy Catamaran's Loss Could Be Long-Term Investors' GainThe market sold off Catamaran today, which could make the pharmacy benefit manager a great buy for long-term Foolish investors.
Feb 27, 2014 by Dave WilliamsonFDA Approval and a Generic-Drug Maker Arms Race Propel WinnersAnika and Mylan were today's big biotech stock winners. Here's why these two drugmakers delivered for investors today.
Feb 24, 2014 by Dave WilliamsonMonday’s Winners and Losers: Celsion Corporation, Celladon Corp, and Amarin Corporation plcCelsion and Celladon Corp scored wins in the health-care space today, while Amarin gets some bad news.
Feb 24, 2014 by Dave WilliamsonObamacare's Medicare Cuts: Cause for CelebrationWhen do you celebrate bad news? When it's not as bad as the terrible news you were expecting.
Feb 22, 2014 by Dave WilliamsonIs Buffett Abandoning Health-Care Stocks?Could Warren Buffett be exiting his positions in the health care sector?
Feb 21, 2014 by Dave WilliamsonWhy Express Scripts Lost Big TodayOne loser in the health-care space today: Express Scripts. Here's what happened.
Feb 21, 2014 by Dave WilliamsonWhy Emeritus Corporation and Isis Pharmaceuticals, Inc Won Huge TodayHere's what drove Emeritus Corporation and Isis Pharmaceuticals skyward today.
Feb 19, 2014 by Dave Williamson3 Stocks Soaring Higher on These Drug SuccessesThree stocks hitting the ceiling today, and the drugs that put them there.
